Michael G Hennerici Selected Research

terutroban

3/2019	Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study.
4/2016	Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.
8/2014	Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial.
10/2013	Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
11/2011	Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
4/2010	Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial.
1/2009	Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael G Hennerici Research Topics

Disease

45	Stroke (Strokes) 01/2021 - 01/2004
31	Ischemic Stroke 03/2019 - 01/2006
12	Transient Ischemic Attack 01/2017 - 12/2008
8	Hemorrhage 01/2021 - 07/2005
7	Coronary Disease (Coronary Heart Disease) 10/2014 - 01/2004
6	Dystonia (Limb Dystonia) 03/2016 - 08/2003
5	Cerebral Hemorrhage 02/2016 - 12/2008
5	Infarction (Infarctions) 08/2014 - 04/2007
4	Atherosclerosis 09/2015 - 03/2010
4	Carotid Stenosis (Carotid Artery Stenosis) 01/2015 - 04/2007
3	Embolic Stroke 01/2021 - 04/2007
3	Neoplasms (Cancer) 01/2018 - 11/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 10/2013
3	Tremor (Tremors) 11/2016 - 02/2007
3	Parkinson Disease (Parkinson's Disease) 03/2016 - 02/2007
3	Carotid Artery Diseases 08/2014 - 12/2008
3	Brain Ischemia (Cerebral Ischemia) 01/2013 - 07/2005
2	Diabetes Mellitus 01/2017 - 10/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 08/2014
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017 - 01/2009
2	Hematoma 02/2016 - 01/2016
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016 - 01/2016
2	Multiple Sclerosis 01/2016 - 07/2014
2	Status Epilepticus (Complex Partial Status Epilepticus) 12/2015 - 09/2015
2	Seizures (Absence Seizure) 12/2015 - 09/2015
2	Myocardial Infarction 10/2013 - 01/2006
2	Pathologic Constriction (Stenosis) 03/2010 - 01/2010
2	Deafness (Deaf Mutism) 10/2004 - 08/2003
1	COVID-19 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Meningioma (Meningiomas) 01/2018
1	Death (Near-Death Experience) 04/2016
1	Deglutition Disorders (Dysphagia) 04/2016
1	Weight Gain 03/2016
1	Body Weight (Weight, Body) 03/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Neurologic Manifestations (Neurological Manifestations) 01/2016
1	Wound Infection (Wound Infections) 01/2016
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016
1	Disease Progression 01/2016

Drug/Important Bio-Agent (IBA)

11	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 07/2005
7	terutrobanIBA 03/2019 - 01/2009
7	CholesterolIBA 10/2014 - 12/2008
6	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2008
6	Atorvastatin (Lipitor)FDA Link 10/2014 - 12/2008
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019 - 12/2008
5	AnticoagulantsIBA 01/2017 - 01/2011
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 01/2004
4	LipidsIBA 04/2015 - 12/2008
3	Neuroprotective AgentsIBA 06/2013 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 04/2016
2	Vitamin K FDA Link 04/2016 - 02/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2016
2	EnzymesIBA 01/2016 - 11/2012
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 06/2007
2	fibrin fragment D (D-dimer)IBA 09/2015 - 11/2012
2	Tissue Inhibitor of Metalloproteinase-2IBA 04/2015 - 01/2009
2	LDL CholesterolIBA 10/2014 - 12/2008
2	Thrombin FDA Link 08/2014 - 01/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2013 - 11/2011
2	Glycoproteins (Glycoprotein)IBA 09/2011 - 01/2006
2	Tirofiban (Aggrastat)FDA Link 09/2011 - 01/2006
2	Triglycerides (Triacylglycerol)IBA 07/2009 - 06/2009
2	oxidized low density lipoproteinIBA 07/2009 - 06/2009
2	Blood Glucose (Blood Sugar)IBA 01/2009 - 12/2008
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 12/2008 - 01/2007
2	Peptides (Polypeptides)IBA 10/2004 - 08/2003
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017
1	ferric oxide (iron oxide)IBA 01/2017
1	danaparoid (Orgaran)FDA Link 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 04/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2016
1	Prothrombin (Factor II)IBA 02/2016
1	N(4)-oleylcytosine arabinosideIBA 02/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016
1	InterleukinsIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016

Therapy/Procedure

13	Therapeutics 01/2018 - 01/2006
6	Deep Brain Stimulation 03/2016 - 02/2007
4	Secondary Prevention 03/2019 - 01/2009
4	Microbubbles 01/2015 - 01/2006
3	Carotid Endarterectomy 01/2017 - 04/2007
3	Thrombolytic Therapy 05/2014 - 01/2006
2	Thrombectomy 01/2021 - 04/2016
2	Lasers (Laser) 06/2013 - 04/2007
1	Off-Label Use 01/2018
1	Stroke Rehabilitation 11/2016
1	Spinal Cord Stimulation 11/2016
1	Terminal Care (Care, Terminal) 04/2016
1	Palliative Care (Palliative Therapy) 04/2016
1	Anticoagulation Reversal 02/2016